Diagnosis Codes in MS-DRG 815 - RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC

The Medicare Severity Diagnosis-Related Group or MS-DRG is a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). This is the group for Diagnosis Codes in MS-DRG 815 - RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH Complication Comorbidity diseases in version MS-DRG V41.0 applicable from 10/01/2023 through 09/30/2024.

MS-DRG	MS-DRG Title	MCD	Relative Weight	Geometric LOS	Arithmetic LOS
815	RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC	16	0.9942 Relative Weight The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.	0.99 Geometric Length of Stay The geometric mean length of stay (GMLOS) is used by Medicare to calculate the reimbursement for patients whose medical treatment takes a much longer or shorter time than average.	3.00 Arithmetic Length of Stay The average length of stay (ALOS) reflects the average number of days a patient spends in a hospital for each admission.

List of ICD-10-CM Codes in Diagnostic Related Group

Filter diagnosis codes list:

A18
- A18.2 Tuberculous peripheral lymphadenopathy
A18.8
- A18.85 Tuberculosis of spleen
A28
- A28.1 Cat-scratch disease
D15
- D15.0 Benign neoplasm of thymus
D18
- D18.1 Lymphangioma, any site
D36
- D36.0 Benign neoplasm of lymph nodes
D3A.09
- D3A.091 Benign carcinoid tumor of the thymus
D47
- D47.2 Monoclonal gammopathy
- D47.3 Essential (hemorrhagic) thrombocythemia
- D47.4 Osteomyelofibrosis
D68.31
- D68.312 Antiphospholipid antibody with hemorrhagic disorder
D68.5
- D68.51 Activated protein C resistance
- D68.52 Prothrombin gene mutation
- D68.59 Other primary thrombophilia
D68.6
- D68.61 Antiphospholipid syndrome
- D68.62 Lupus anticoagulant syndrome
- D68.69 Other thrombophilia
D72.1
- D72.10 Eosinophilia, unspecified
- D72.12 Drug rash with eosinophilia and systemic symptoms syndrome
- D72.18 Eosinophilia in diseases classified elsewhere
- D72.19 Other eosinophilia
D72.11
- D72.110 Idiopathic hypereosinophilic syndrome [IHES]
- D72.111 Lymphocytic Variant Hypereosinophilic Syndrome [LHES]
- D72.118 Other hypereosinophilic syndrome
- D72.119 Hypereosinophilic syndrome [HES], unspecified
D72.81
- D72.810 Lymphocytopenia
- D72.818 Other decreased white blood cell count
- D72.819 Decreased white blood cell count, unspecified
D72.82
- D72.820 Lymphocytosis (symptomatic)
- D72.821 Monocytosis (symptomatic)
- D72.822 Plasmacytosis
- D72.823 Leukemoid reaction
- D72.824 Basophilia
- D72.825 Bandemia
- D72.828 Other elevated white blood cell count
- D72.829 Elevated white blood cell count, unspecified
D72.8
- D72.89 Other specified disorders of white blood cells
D72
- D72.9 Disorder of white blood cells, unspecified
D73
- D73.0 Hyposplenism
- D73.1 Hypersplenism
- D73.2 Chronic congestive splenomegaly
- D73.3 Abscess of spleen
- D73.4 Cyst of spleen
- D73.5 Infarction of spleen
- D73.9 Disease of spleen, unspecified
D73.8
- D73.81 Neutropenic splenomegaly
- D73.89 Other diseases of spleen
D75
- D75.0 Familial erythrocytosis
- D75.1 Secondary polycythemia
- D75.9 Disease of blood and blood-forming organs, unspecified
- D75.A Glucose-6-phosphate dehydrogenase (G6PD) deficiency without anemia
D75.83
- D75.838 Other thrombocytosis
- D75.839 Thrombocytosis, unspecified
D75.8
- D75.89 Other specified diseases of blood and blood-forming organs
D76
- D76.1 Hemophagocytic lymphohistiocytosis
- D76.2 Hemophagocytic syndrome, infection-associated
- D76.3 Other histiocytosis syndromes
- D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere
- R75 Inconclusive laboratory evidence of human immunodeficiency virus [HIV]
D80
- D80.0 Hereditary hypogammaglobulinemia
- D80.1 Nonfamilial hypogammaglobulinemia
- D80.2 Selective deficiency of immunoglobulin A [IgA]
- D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses
- D80.4 Selective deficiency of immunoglobulin M [IgM]
- D80.5 Immunodeficiency with increased immunoglobulin M [IgM]
- D80.7 Transient hypogammaglobulinemia of infancy
D82
- D82.2 Immunodeficiency with short-limbed stature
- D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus
- D82.4 Hyperimmunoglobulin E [IgE] syndrome
- D82.8 Immunodeficiency associated with other specified major defects
- D82.9 Immunodeficiency associated with major defect, unspecified
D83
- D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
- D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
- D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells
- D83.8 Other common variable immunodeficiencies
- D83.9 Common variable immunodeficiency, unspecified
D84
- D84.0 Lymphocyte function antigen-1 [LFA-1] defect
- D84.9 Immunodeficiency, unspecified
D84.8
- D84.81 Immunodeficiency due to conditions classified elsewhere
- D84.89 Other immunodeficiencies
D84.82
- D84.821 Immunodeficiency due to drugs
- D84.822 Immunodeficiency due to external causes
D89
- D89.0 Polyclonal hypergammaglobulinemia
- D89.2 Hypergammaglobulinemia, unspecified
- D89.3 Immune reconstitution syndrome
- D89.9 Disorder involving the immune mechanism, unspecified
D89.4
- D89.40 Mast cell activation, unspecified
- D89.41 Monoclonal mast cell activation syndrome
- D89.42 Idiopathic mast cell activation syndrome
- D89.43 Secondary mast cell activation
- D89.44 Hereditary alpha tryptasemia
- D89.49 Other mast cell activation disorder
D89.83
- D89.831 Cytokine release syndrome, grade 1
- D89.832 Cytokine release syndrome, grade 2
- D89.833 Cytokine release syndrome, grade 3
- D89.834 Cytokine release syndrome, grade 4
- D89.835 Cytokine release syndrome, grade 5
- D89.839 Cytokine release syndrome, grade unspecified
D89.8
- D89.84 IgG4-related disease
- D89.89 Other specified disorders involving the immune mechanism, not elsewhere classified
E32
- E32.0 Persistent hyperplasia of thymus
- E32.8 Other diseases of thymus
- E32.9 Disease of thymus, unspecified
I88
- I88.1 Chronic lymphadenitis, except mesenteric
- I88.8 Other nonspecific lymphadenitis
- I88.9 Nonspecific lymphadenitis, unspecified
I89
- I89.8 Other specified noninfective disorders of lymphatic vessels and lymph nodes
- I89.9 Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
Q89.0
- Q89.01 Asplenia (congenital)
- Q89.09 Congenital malformations of spleen
R16
- R16.1 Splenomegaly, not elsewhere classified
R59
- R59.0 Localized enlarged lymph nodes
- R59.1 Generalized enlarged lymph nodes
- R59.9 Enlarged lymph nodes, unspecified
R76
- R76.0 Raised antibody titer
- R76.8 Other specified abnormal immunological findings in serum
- R76.9 Abnormal immunological finding in serum, unspecified
Z94.8
- Z94.81 Bone marrow transplant status
- Z94.84 Stem cells transplant status